Natera reports Q1 2026 earnings, releases investor presentation

Natera announced its first quarter 2026 financial results on May 7, 2026, through a standard earnings disclosure filing. The company issued both a press release and an investor presentation, which are attached as exhibits to the 8-K. This is a routine quarterly earnings announcement required under SEC rules, with the detailed financial metrics contained in the exhibits rather than the filing body itself.

Retail investors should review the attached press release (Exhibit 99.1) and investor presentation (Exhibit 99.2) for the actual revenue, earnings, and guidance figures. These documents will contain the key performance metrics for Natera's prenatal and oncology testing businesses during the quarter. Watch for management commentary on any guidance updates or strategic initiatives discussed in the earnings materials, as those will signal the company's near-term trajectory.